[go: up one dir, main page]

PT2596119T - Métodos para a deteção de subpopulações raras de células e composições de células altamente purificadas - Google Patents

Métodos para a deteção de subpopulações raras de células e composições de células altamente purificadas

Info

Publication number
PT2596119T
PT2596119T PT118105188T PT11810518T PT2596119T PT 2596119 T PT2596119 T PT 2596119T PT 118105188 T PT118105188 T PT 118105188T PT 11810518 T PT11810518 T PT 11810518T PT 2596119 T PT2596119 T PT 2596119T
Authority
PT
Portugal
Prior art keywords
cells
detection
methods
highly purified
purified compositions
Prior art date
Application number
PT118105188T
Other languages
English (en)
Original Assignee
Astellas Inst For Regenerative Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Inst For Regenerative Medicine filed Critical Astellas Inst For Regenerative Medicine
Publication of PT2596119T publication Critical patent/PT2596119T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT118105188T 2010-07-23 2011-07-25 Métodos para a deteção de subpopulações raras de células e composições de células altamente purificadas PT2596119T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36703810P 2010-07-23 2010-07-23
US41477010P 2010-11-17 2010-11-17

Publications (1)

Publication Number Publication Date
PT2596119T true PT2596119T (pt) 2021-06-18

Family

ID=45497502

Family Applications (2)

Application Number Title Priority Date Filing Date
PT118105188T PT2596119T (pt) 2010-07-23 2011-07-25 Métodos para a deteção de subpopulações raras de células e composições de células altamente purificadas
PT211637681T PT3875599T (pt) 2010-07-23 2011-07-25 Métodos para deteção de subpopulações raras de células e composições altamente purificadas de células

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT211637681T PT3875599T (pt) 2010-07-23 2011-07-25 Métodos para deteção de subpopulações raras de células e composições altamente purificadas de células

Country Status (11)

Country Link
US (2) US11739366B2 (pt)
EP (3) EP2596119B8 (pt)
JP (5) JP6184865B2 (pt)
AU (1) AU2011280878B2 (pt)
CA (1) CA2806127C (pt)
DK (2) DK3875599T3 (pt)
ES (2) ES3013241T3 (pt)
HU (1) HUE054517T2 (pt)
PL (2) PL2596119T3 (pt)
PT (2) PT2596119T (pt)
WO (1) WO2012012803A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX375065B (es) 2004-01-23 2025-03-06 Harvard College Composiciones para usarse en el tratamiento de enfermedades degenerativas de la retina.
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
PT2209888T (pt) 2007-10-12 2020-01-17 Astellas Inst For Regenerative Medicine Métodos aperfeiçoados de produção de células rpe e composições de células rpe
DK3633025T3 (da) 2009-11-12 2022-12-12 Technion Res & Dev Foundation Dyrkningsmedier, cellekulturer og metoder til dyrkning af pluripotente stamceller i en udifferentieret tilstand
WO2011063005A2 (en) 2009-11-17 2011-05-26 Advanced Cell Technology, Inc. Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
PT2596119T (pt) 2010-07-23 2021-06-18 Astellas Inst For Regenerative Medicine Métodos para a deteção de subpopulações raras de células e composições de células altamente purificadas
AU2012340020A1 (en) * 2011-11-14 2014-07-03 Astellas Institute For Regenerative Medicine Pharmaceutical preparations of human RPE cells and uses thereof
CA2858173C (en) 2011-12-06 2023-09-26 Advanced Cell Technology, Inc. Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof
JP6090735B2 (ja) * 2012-03-02 2017-03-08 国立大学法人山口大学 消化器系がん幹細胞を培養するための無血清培地、及びそれを用いた消化器系がん幹細胞の増殖方法
HK1208371A1 (en) * 2012-10-09 2016-03-04 桑比欧公司 Methods and compositions for treatment of retinal degeneration
EP2980585B1 (en) * 2013-03-29 2019-11-20 Mie University Vital stain
WO2015045962A1 (ja) * 2013-09-26 2015-04-02 コニカミノルタ株式会社 組織切片における生体物質の定量法
CA2951746C (en) * 2014-06-10 2023-08-22 Polybiocept Ab Culture medium for cellular immunotherapy
JP6271407B2 (ja) * 2014-12-17 2018-01-31 富士フイルム株式会社 細胞評価統合方法
JP6459568B2 (ja) * 2015-01-30 2019-01-30 コニカミノルタ株式会社 目的細胞の検出方法および目的細胞検出システム
CN104833805A (zh) * 2015-03-09 2015-08-12 武汉格蓝丽富科技有限公司 一种循环肿瘤细胞检测和鉴定试剂盒及其应用
CN113930476B (zh) 2015-03-23 2024-11-12 安斯泰来再生医药协会 改进的人视网膜色素（rpe）细胞和感光祖细胞的效能测定
SG10201913250SA (en) 2015-08-18 2020-03-30 Astellas Inst For Regenerative Medicine Clinical formulations
WO2017100498A1 (en) 2015-12-11 2017-06-15 The Johns Hopkins University Isolation of fusion-competent myoblasts and therapeutic applications thereof related to muscular dystrophy
CN106053196B (zh) * 2016-05-23 2019-02-15 无锡帝科电子材料股份有限公司 一种光伏正面银浆用银粉粒度测试的分散方法
CN106525541B (zh) * 2016-09-20 2019-01-18 广东东阳光药业有限公司 一种鲜冬虫夏草细胞活力的检测方法
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
WO2018225705A1 (ja) 2017-06-05 2018-12-13 テルモ株式会社 細胞培養物の製造方法
WO2020067438A1 (ja) 2018-09-27 2020-04-02 国立大学法人大阪大学 多能性幹細胞由来細胞のシート化方法
KR102224273B1 (ko) * 2019-10-10 2021-03-08 고려대학교 산학협력단 줄기세포 유래 성숙 심근세포 및 이를 이용한 심혈관 질환 모델
AU2020374884A1 (en) 2019-10-30 2022-06-09 Astellas Institute For Regenerative Medicine Methods for producing retinal pigment epithelium cells
CN112461807B (zh) * 2020-11-26 2021-11-19 山西大学 碳量子点在靶向细胞核仁免洗成像中的应用

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7A (en) 1836-08-10 Thomas Blanchard Machine for boring holes and cutting lanyard-scores in deadeyes
US5610753A (en) 1991-12-12 1997-03-11 Eastman Kodak Company Optical design of laser scanner to reduce thermal sensitivity
US5780300A (en) * 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
AU1802797A (en) * 1996-02-16 1997-09-02 University Of Edinburgh, The Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
DE19609838A1 (de) * 1996-03-13 1997-09-18 Boehringer Mannheim Gmbh Verfahren und Teststreifen zur Bestimmung eines Analyten
FR2754544B1 (fr) 1996-10-10 1998-11-06 Lorraine Laminage Tole aluminiee a faible emissivite
US6440933B1 (en) 1997-09-10 2002-08-27 University Of Florida Compounds and method for the prevention and treatment of diabetic retinopathy
EP1025204A4 (en) 1997-10-23 2001-02-28 Geron Corp Methods and materials for the growth of primate-derived primordial stem cells
US6322901B1 (en) 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
EP1066368A4 (en) 1998-03-02 2002-08-21 Compucyte Corp SELECTIVE CELL ANALYSIS
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6943153B1 (en) 1999-03-15 2005-09-13 The Regents Of The University Of California Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US20080194022A1 (en) 2000-08-03 2008-08-14 Clarke Michael F Isolation and use of solid tumor stem cells
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
ATE306951T1 (de) 2000-11-29 2005-11-15 Allergan Inc Verhinderung von transplantatabstossung im auge
US6576291B2 (en) 2000-12-08 2003-06-10 Massachusetts Institute Of Technology Preparation of nanocrystallites
US20020083888A1 (en) 2000-12-28 2002-07-04 Zehnder Donald A. Flow synthesis of quantum dot nanocrystals
AU2002243754A1 (en) * 2001-02-02 2002-08-19 Dana-Farber Cancer Institute, Inc Rare event detection system
EP1666881B1 (en) * 2001-05-04 2010-02-17 Biosite Incorporated Diagnostic markers of acute coronary syndromes and methods of use thereof
KR20040022448A (ko) * 2001-07-12 2004-03-12 제론 코포레이션 인간 다분화능 줄기 세포로부터 제조된 심근 세포 계통의세포
ATE556845T1 (de) 2001-07-20 2012-05-15 Life Technologies Corp Lumineszierende nanopartikel und ihre herstellung
KR20040030161A (ko) 2001-08-23 2004-04-08 리라이언스 라이프 사이언시스 프라이빗. 리미티드 인간 배 줄기 세포(ｈＥＳＣ)주를 확립하기 위한 내부세포 덩어리의 분리 방법
WO2003046141A2 (en) 2001-11-26 2003-06-05 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
AU2003235652A1 (en) 2002-01-15 2003-07-30 Advanced Cell Technology, Inc. Cloning b and t lymphocytes
US20040091936A1 (en) 2002-05-24 2004-05-13 Michael West Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
US7662625B2 (en) * 2002-07-02 2010-02-16 Cancer Research Technology Limited Methods for detecting the differentiation status of cells using 5T4 antigen expression
AU2003302020B2 (en) 2002-11-14 2008-01-31 Ethicon Endo-Surgery, Inc. Methods and devices for detecting tissue cells
EP1599730A2 (en) * 2003-03-03 2005-11-30 Kouyama, Yoshihisa Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
JP4740862B2 (ja) 2003-05-07 2011-08-03 インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション 合金化された半導体量子ドットおよび合金化された濃度勾配量子ドット、これらの量子ドットを含むシリーズ、ならびにこれらに関する方法
US20050118713A1 (en) * 2003-05-12 2005-06-02 Nikolai Strelchenko Morula derived embryonic stem cells
KR100657891B1 (ko) 2003-07-19 2006-12-14 삼성전자주식회사 반도체 나노결정 및 그 제조방법
KR100569168B1 (ko) * 2003-08-08 2006-04-07 (주)아비코아생명공학연구소 조류 정원줄기세포의 배양방법 및 이에 의해 수득한 조류정원줄기세포
US20190282622A1 (en) 2004-01-23 2019-09-19 Astellas Institute For Regenerative Medicine Modalities for the treatment of degenerative diseases of the retina
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
MX375065B (es) 2004-01-23 2025-03-06 Harvard College Composiciones para usarse en el tratamiento de enfermedades degenerativas de la retina.
ES2383813T3 (es) 2004-09-08 2012-06-26 Wisconsin Alumni Research Foundation Método de cultivo y cultivo de células madre embrionarias
US7893315B2 (en) * 2004-11-04 2011-02-22 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
AU2005304978A1 (en) 2004-11-04 2006-05-18 Advanced Cell Technology, Inc. Derivation of embryonic stem cells
US7723112B2 (en) 2005-10-31 2010-05-25 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20070160974A1 (en) 2006-01-10 2007-07-12 South Eastern Sydney And Illawarra Area Health Service Human embryonic stem cell clones
CZ301148B6 (cs) * 2006-01-25 2009-11-18 Univerzita Karlova V Praze Zpusob pestování lidských mezenchymových kmenových bunek, zejména pro lécbu nehojících se fraktur, a bioreaktor k provádení tohoto zpusobu
EP1994163A4 (en) 2006-03-16 2009-04-01 Health Research Inc INHIBITION OF THE GROWTH OF BREAST CARCINOMA STEM CELLS AND METASTASES
KR100832592B1 (ko) * 2006-08-17 2008-05-27 박현숙 폴리머 막을 이용한 줄기세포와 피더세포의 공배양방법
CN101855339A (zh) 2007-01-22 2010-10-06 雷文生物技术公司 人类癌症干细胞
US8097588B2 (en) * 2007-02-08 2012-01-17 Sanford-Burnham Medical Research Institute Trophinin-binding peptides and uses thereof
CN101688178B (zh) 2007-04-18 2013-12-04 哈达锡特医学研究服务及发展有限公司 干细胞衍生的视网膜色素上皮细胞
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
PT2209888T (pt) 2007-10-12 2020-01-17 Astellas Inst For Regenerative Medicine Métodos aperfeiçoados de produção de células rpe e composições de células rpe
HU0700675D0 (en) 2007-10-15 2007-12-28 Mta Tamogatott Kutatohelyek Ir Method for monitoring stem cell differentiation
US20090123439A1 (en) * 2007-11-09 2009-05-14 The Jackson Laboratory Diagnostic and prognosis methods for cancer stem cells
US20090233324A1 (en) * 2008-03-11 2009-09-17 Kopf-Sill Anne R Methods for Diagnosing Cancer Using Samples Collected From A Central Vein Location or an Arterial Location
WO2011063005A2 (en) 2009-11-17 2011-05-26 Advanced Cell Technology, Inc. Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
PT2596119T (pt) 2010-07-23 2021-06-18 Astellas Inst For Regenerative Medicine Métodos para a deteção de subpopulações raras de células e composições de células altamente purificadas
US20120258451A1 (en) 2011-04-08 2012-10-11 Advanced Cell Technology, Inc. Laser isolation of viable cells
AU2012340020A1 (en) 2011-11-14 2014-07-03 Astellas Institute For Regenerative Medicine Pharmaceutical preparations of human RPE cells and uses thereof
CN113930476B (zh) 2015-03-23 2024-11-12 安斯泰来再生医药协会 改进的人视网膜色素（rpe）细胞和感光祖细胞的效能测定

Also Published As

Publication number Publication date
CA2806127C (en) 2021-12-21
AU2011280878B2 (en) 2016-06-16
EP2596119A4 (en) 2013-12-04
EP2596119A2 (en) 2013-05-29
EP4524568A2 (en) 2025-03-19
US11739366B2 (en) 2023-08-29
JP6630657B2 (ja) 2020-01-15
DK2596119T3 (da) 2021-07-26
JP7125382B2 (ja) 2022-08-24
DK3875599T3 (da) 2025-01-20
PL3875599T3 (pl) 2025-03-24
ES3013241T3 (en) 2025-04-11
JP2022095696A (ja) 2022-06-28
JP2020048573A (ja) 2020-04-02
JP2024026528A (ja) 2024-02-28
JP7412470B2 (ja) 2024-01-12
ES2874953T3 (es) 2021-11-05
EP4524568A3 (en) 2025-06-18
PL2596119T3 (pl) 2021-12-06
PT3875599T (pt) 2025-01-22
US20130302824A1 (en) 2013-11-14
JP7788436B2 (ja) 2025-12-18
US20240026419A1 (en) 2024-01-25
EP2596119B1 (en) 2021-04-28
EP3875599A1 (en) 2021-09-08
EP2596119B8 (en) 2021-06-02
EP3875599B1 (en) 2024-12-11
JP6184865B2 (ja) 2017-08-23
JP2017079752A (ja) 2017-05-18
JP2013535194A (ja) 2013-09-12
CA2806127A1 (en) 2012-01-26
HUE054517T2 (hu) 2021-09-28
WO2012012803A3 (en) 2012-11-01
WO2012012803A2 (en) 2012-01-26

Similar Documents

Publication Publication Date Title
PL2596119T3 (pl) Sposoby wykrywania rzadkich subpopulacji komórek i kompozycje wysoko oczyszczonych komórek
ZA201304337B (en) Soybean event syht0h2 and compositions and methods for detection thereof
EP2526183A4 (en) Magnetic separation of rare cells
SG10201506767QA (en) Identification and enrichment of cell subpopulations
IL224390B (en) Compositions and methods for targeted thermal modulation
EP2566930A4 (en) COOLING COMPOSITIONS AND METHODS
AP2013006950A0 (en) Compositions and methods for detection and management of malaria
PL2385029T3 (pl) Kompozycje i sposób cementowania odwiertów
EP2577536A4 (en) Methods and compositions for predicting unobserved phenotypes (pup)
IL274395B (en) Subpopulations of spore-like cells and their uses
GB201005675D0 (en) System for the detection of incoming muntions
SG10201509539UA (en) Methods And Compositions For Inhibition Of Treg Cells
GB201018650D0 (en) Methods and compositions
EP2536799A4 (en) Laminated compositions and methods
IL223223A0 (en) Compositions and methods for reduction of mercury toxicity
EP2614162A4 (en) DETECTION OF A CHROMATIN STRUCTURE
EP2531224A4 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH ARGININOSUCCINATE SYNTHASE
EP2805962A4 (en) IMMUNOMODULATORY METALLOPEPTIDES (IMMP) AND COMPOSITIONS CONTAINING THE SAME
WO2012162108A9 (en) Boron-containing compositions and methods therefor
AU2010901300A0 (en) Methods for detection of doping and compositions thereof
GB201004238D0 (en) Presymptomatic detection of infection in an individual
IL221023A0 (en) Magnetic separation of rare cells
LU91725B1 (en) Novel uses of V-ATPASE inhibitors
HK1184713A (en) METHODS AND COMPOSITIONS FOR CNS DELIVERY OF β-GALACTOCEREBROSIDASE
AU2010902782A0 (en) An enclosure for transporting people to and from high-altitudes